Benign and hyperplastic endometrial changes associated with tamoxifen use.

Abstract

For nearly 20 years, tamoxifen has been successfully used in the management of breast cancer. Tamoxifen is a mixed estrogen agonist/antagonist that has a proliferative effect on the endometrium. The drug has been associated with a higher percentage of endometrial polyps and hyperplasia than in control patients as well as slightly increased risk of… (More)

Topics

Cite this paper

@article{Barakat1997BenignAH, title={Benign and hyperplastic endometrial changes associated with tamoxifen use.}, author={Richard R. Barakat}, journal={Oncology}, year={1997}, volume={11 2 Suppl 1}, pages={35-7} }